Cognitive-behavioral group therapy versus phenelzine in social phobia: Long term outcome

Depression and Anxiety

Volumn 10, Issue 3, 1999, Pages 89-98

  Liebowitz, Michael R ^a,b,c   Heimberg, Richard G ^a,b,c   Schneier, Franklin R ^a,b,c   Hope, Debra A ^a,b,c   Davies, Sharon ^a,b,c   Holt, Craig S ^a,b,c   Goetz, Deborah ^a,b,c   Juster, Harlan R ^a,b,c   Lin, Shu Hsing ^a,b,c   Bruch, Monroe A ^a,b,c   Marshall, Randall D ^a,b,c   Klein, Donald F ^a,b,c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c TEMPLE UNIVERSITY   (United States)

Author keywords

Cognitive behavioral group therapy; Discontinuation; Follow up; Maintenance; Phenelzine

Indexed keywords

PHENELZINE;

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PSYCHOPHARMACOTHERAPY; RELAPSE; SOCIAL PHOBIA; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COGNITIVE THERAPY; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MONOAMINE OXIDASE INHIBITORS; PATIENT DROPOUTS; PHENELZINE; PHOBIC DISORDERS; PROGNOSIS; PSYCHOTHERAPY, GROUP; RECURRENCE;

EID: 0032753601     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1999)10:3<89::AID-DA1>3.0.CO;2-5     Document Type: Article

References (32)

1. Black DW, Wesner R, Bowers W, Gabel J. 1993. A comparison of fluvoxamine cognitive therapy and placebo in the treatment of panic disorder. Arch Gen Psychiatry 50:44-50.
2. Brown EJ, Heimberg RG, Juster HR. 1995. Social phobia subtype and avoidant personality disorder: Effect on severity of social phobia, impairment, and outcome of cognitive behavioral treatment. Behav Ther 26:467-486.
3. Clark DM, Salkovskis PM, Hackman A, Middleton H, Anastasiades P, Gelder AI. 1994. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 164:759-769.
4. Clark DB, Agras WS. 1991. The assessment and treatment of performance anxiety in musicians. Am J Psychiatry 148:598-605.
5. DiNardo PA, Aloras K, Barlow DH, Rapee RAI, Brown TA. 1993. Reliability of DSM-IIIR Anxiety disorder categories: Using the Anxiety Interview Schedule-Revised. Arch Gen Psychiatry 50:251-256.
6. Falloon IRH, Lloyd GG, Harpin RE. 1981. The treatment of social phobia: Real-life rehearsal with nonprofessional therapists. J Nerv Men Disease 169:180-184.
7. Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer AIE, BartkoJJ. 1991. Cognitive-behavioral and pharmacological treatments of social phobia: A controlled study. Arch Gen Psychiatry 48:938-945.
8. Heimberg RG, Horner KJ, Juster HR, Safren SA, Brown EJ,
9. Schneier FR, Liebowitz MR. 1999. Psychometric properties of the Liebowitz Social Anxiety Scale. Psych Aled. 29:199-212.
10. Heimberg RG, Dodge CS, Hope DA, Kennedy CR, Zollo L, Becker RE. 1990. Cognitive-behavioral group treatment of social phobia: Comparison with a credible placebo control. Cognitive Ther Res 14:1-23.
11. Heimberg RG, Holt CS, Schneier FR, Spitzer RL, Liebowitz MR. 1993b. The issue of subtypes in the diagnosis of social phobia. J Anx Disord 7:249-269.
12. Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz L, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF. 1998. Cognitive-behavioral group therapy versus phenelzine in social phobia: 12 week outcome. Arch Gen Psychiatry 55:1133-1141.
13. Heimberg RG, Mueller GP, Holt CS, Hope DA, Liebowitz MR. 1992. Assessment of anxiety in social interactions and being observed by others. The Social Interaction Anxiety Scale and Social Phobia Scale. Beh Ther 23:53-73.
14. Heimberg RG, Salzman D, Holt CS, Blendell K. 1993a. Cognitivebehavioral group treatment of social phobia: Effectiveness at 5year follow-up. Cognitive Ther Res 17:325-339.
15. Hope DA, Herbert JD, White C. 1995. Diagnostic subtype, avoidant personality disorder and efficacy of cognitive-behavioral group therapy for social phobia. Cognitive Ther Res 19:399-417.
16. Juster HR, Heimberg RG. 1995. Social phobia: Longitudinal course and long-term outcome of cognitive-behavioral treatment. Psychiatric Clinics North America 18:821-842.
17. Leung AW, Heimberg RG. 1996. Homework compliance, perceptions of control, and outcome of cognitive-behavioral treatment of social phobia. Behav Res Ther 34(5-6):423-432.
18. Levin AP, Saoud JB, Strauman T, Gorman JM, Fryer AJ, Crawford R, Liebowitz AIR. 1993. Responses of "generalized: and "discrete" social phobies during public speaking. J Anx Disord 7:207-221.
19. Liebowitz MR. 1987. Social phobia. Mod Probl Pharmacopsychiatry 22:141-173.
20. Liebowitz AIR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman J, Papp L, Davies S, Gully R, Klein DR. 1992.
21. Phenelzine vs atenolol in social phobia: A placebo-controlled comparison. Arch Gen Psychiatry 49:290-300.
22. Marks LM, Mathews AM. 1979. Brief standard self-rating for phobic patients. Beh Res Ther 17:263-267.
23. Alattick RP, Peters L. 1988. Treatment of several social phobia: Effects of guided exposure with and without cognitive restructuring.; Consult Clin Psychology 56:251-260.
24. Alattick RP, Peters L, Clarke JC. 1989. Exposure and cognitive restructuring for social phobia: A controlled study. Behav Ther 20:3-23.
25. Mattick RP, Clarke JC. 1998. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Beh Res Ther 3 6:45 5-470.
26. Otto AIW, Pollack MH, Gould RA, Worthington JJ, Heimberg RG, McArdle BA, Rosenbaum JE (in press) A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. J Anx Disord.
27. Reich J, Goldenberg I, Vasile R, Goisman R, Keller M. 1994. A prospective follow-along study of the course of social phobia. Psychiatric Res 54:249-258.
28. Stein MB, Liebowitz MR, Lydiard RB, Pitts CD, Bushnell W, Gergel. 1998. Paroxetine treatment of generalized social phobia (social anxiety, disorder): A randomized, double-blind, placebo controfled study. J of the Am Med Assoc (JAMA) 280:70887113.
29. Turner SM, Beidel DC, Jacob R. 1994. Social phobia: A comparison of behavior therapy and atenolol. J Consult Clin Psychology 62:350-358.
30. van Vliet LM, den Boer JA, Westember HG. 1994. Psychopharmacological treatment of social phobia: a double blind placebo controlled study with fluvoxamine. Psychopharmacology 115: 128-134.
31. Versiani M, Nardi AE, Alundin FD, Alves AB, Liebowitz AIR, Amrein. 1992. Pharmacotherapy of social phobia: A controlled study with moclobemide and phenelzine. Br J Psychiatry 161: 353-360.
32. Watson D, Friend R. 1969. Aleasurement of social-evaluative anxiety. J Consult Clin Psychology 33:448-457.